Therefore, studying how TRIP13 regulates the development of ccRCC through mitochondrial autophagy will not only help to reveal the pathogenesis of ccRCC, but may also provide new ideas for the development of therapeutic strategies targeting TRIP13 or combining mitochondrial autophagy inhibitors. This evidence concerns the gene TRIP13 and nonpapillary renal cell carcinoma.